Further processing options
Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc)
Saved in:
Journal Title: | Annals of Oncology |
---|---|
Authors and Corporations: | , , , , , , , |
In: | Annals of Oncology, 25, 2014, p. iv514 |
Type of Resource: | E-Article |
Language: | English |
published: |
Elsevier BV
|
Subjects: |